These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 31307045)

  • 21. Cortisol, the cortisol-dehydroepiandrosterone ratio, and pro-inflammatory cytokines in patients with current major depressive disorder comorbid with borderline personality disorder.
    Kahl KG; Bens S; Ziegler K; Rudolf S; Dibbelt L; Kordon A; Schweiger U
    Biol Psychiatry; 2006 Apr; 59(7):667-71. PubMed ID: 16199015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: a cytokine antibody array analysis.
    Lu S; Peng H; Wang L; Vasish S; Zhang Y; Gao W; Wu W; Liao M; Wang M; Tang H; Li W; Li W; Li Z; Zhou J; Zhang Z; Li L
    Compr Psychiatry; 2013 Oct; 54(7):953-61. PubMed ID: 23639406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ligands and receptors of the TNF superfamily are decreased in major depression and during early antidepressant therapy.
    Schmidt FM; Koch J; Nowak C; Holdt LM; Teupser D; Hegerl U; Himmerich H
    J Psychiatr Res; 2019 Dec; 119():116-121. PubMed ID: 31622870
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pathogenetic and Therapeutic Applications of Tumor Necrosis Factor-α (TNF-α) in Major Depressive Disorder: A Systematic Review.
    Ma K; Zhang H; Baloch Z
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between toll-like receptors expression and major depressive disorder.
    Hung YY; Kang HY; Huang KW; Huang TL
    Psychiatry Res; 2014 Dec; 220(1-2):283-6. PubMed ID: 25155940
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Toll-Like Receptors in peripheral blood mononuclear cells and response to cognitive-behavioral therapy in major depressive disorder.
    Kéri S; Szabó C; Kelemen O
    Brain Behav Immun; 2014 Aug; 40():235-43. PubMed ID: 24726793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Difference in proinflammatory cytokines produced by monocytes between patients with major depressive disorder and healthy controls.
    Zhang HX; Xu YQ; Li YY; Lu MF; Shi SX; Ji JL; Wang LW
    J Affect Disord; 2018 Jul; 234():305-310. PubMed ID: 29587166
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pro- and anti-inflammatory cytokines, but not CRP, are inversely correlated with severity and symptoms of major depression.
    Schmidt FM; Schröder T; Kirkby KC; Sander C; Suslow T; Holdt LM; Teupser D; Hegerl U; Himmerich H
    Psychiatry Res; 2016 May; 239():85-91. PubMed ID: 27137966
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased serum tumor necrosis factor-alpha levels and treatment response in major depressive disorder.
    Tuglu C; Kara SH; Caliyurt O; Vardar E; Abay E
    Psychopharmacology (Berl); 2003 Dec; 170(4):429-33. PubMed ID: 12955291
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of tumor necrosis factor alpha-induced protein 3 mRNA in peripheral blood mononuclear cells negatively correlates with disease severity in psoriasis vulgaris.
    Jiang X; Tian H; Fan Y; Chen J; Song Y; Wang S; Zhu F; Guo C; Zhang L; Shi Y
    Clin Vaccine Immunol; 2012 Dec; 19(12):1938-42. PubMed ID: 23054742
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Specific overexpression of tumour necrosis factor-α-induced protein (TNFAIP)9 in CD14(+) CD16(-) monocytes in patients with rheumatoid arthritis: comparative analysis with TNFAIP3.
    Takai C; Matsumoto I; Inoue A; Umeda N; Tanaka Y; Kurashima Y; Wada Y; Narita I; Sumida T
    Clin Exp Immunol; 2015 Jun; 180(3):458-66. PubMed ID: 25683200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intracellular inflammatory and antioxidant pathways in postmortem frontal cortex of subjects with major depression: effect of antidepressants.
    Martín-Hernández D; Caso JR; Javier Meana J; Callado LF; Madrigal JLM; García-Bueno B; Leza JC
    J Neuroinflammation; 2018 Sep; 15(1):251. PubMed ID: 30180869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Might different cytokine trends in depressed patients receiving duloxetine indicate differential biological backgrounds.
    Fornaro M; Rocchi G; Escelsior A; Contini P; Martino M
    J Affect Disord; 2013 Mar; 145(3):300-7. PubMed ID: 22981313
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytokine imbalance in the pathophysiology of major depressive disorder.
    Kim YK; Na KS; Shin KH; Jung HY; Choi SH; Kim JB
    Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1044-53. PubMed ID: 17433516
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment.
    Yao L; Pan L; Qian M; Sun W; Gu C; Chen L; Tang X; Hu Y; Xu L; Wei Y; Hui L; Liu X; Wang J; Zhang T
    Front Psychiatry; 2020; 11():518837. PubMed ID: 33364982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between toll-like receptor 4 expression and symptoms of major depressive disorder.
    Wu MK; Huang TL; Huang KW; Huang YL; Hung YY
    Neuropsychiatr Dis Treat; 2015; 11():1853-7. PubMed ID: 26257523
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant treatment resistance is associated with increased inflammatory markers in patients with major depressive disorder.
    Haroon E; Daguanno AW; Woolwine BJ; Goldsmith DR; Baer WM; Wommack EC; Felger JC; Miller AH
    Psychoneuroendocrinology; 2018 Sep; 95():43-49. PubMed ID: 29800779
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in immunomodulatory properties between venlafaxine and paroxetine in patients with major depressive disorder.
    Chen CY; Yeh YW; Kuo SC; Liang CS; Ho PS; Huang CC; Yen CH; Shyu JF; Lu RB; Huang SY
    Psychoneuroendocrinology; 2018 Jan; 87():108-118. PubMed ID: 29055264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antidepressants induce autophagy dependent-NLRP3-inflammasome inhibition in Major depressive disorder.
    Alcocer-Gómez E; Casas-Barquero N; Williams MR; Romero-Guillena SL; Cañadas-Lozano D; Bullón P; Sánchez-Alcazar JA; Navarro-Pando JM; Cordero MD
    Pharmacol Res; 2017 Jul; 121():114-121. PubMed ID: 28465217
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low cocaine- and amphetamine-regulated transcript (CART) peptide levels in human cerebrospinal fluid of major depressive disorder (MDD) patients.
    Yoon HS; Hattori K; Sasayama D; Kunugi H
    J Affect Disord; 2018 May; 232():134-138. PubMed ID: 29486339
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.